ViiV Announces Expanded Access to Once-a-Day Integrase Inhibitor ... But Activists Are Concerned About Its Potential MisuseMarch 7, 2012 The dolutegravir expanded access program (EAP) has been designed to provide free access to Shionogi-ViiV Healthcare's investigational integrase inhibitor, dolutegravir (DTG, S/GSK1349572) in an open-label protocol program to adults living with HIV who have documented raltegravir or elvitegravir resistance, who have limited treatment options, and who require DTG to construct a viable antiretroviral regimen for therapy. But before you consider the use of this new drug, read the following warning: Activists Advise Caution About Access Program The dolutegravir EAP is available to adults living with HIV who (Note: Not all inclusion criteria are listed): View Full Article
Comment by: Bruce
(Sikeston Mo)
Mon., Feb. 18, 2013 at 9:35 am UTC Why?Three years ago i had a problem keeping my bilyruben where it was suposed to be.I go once a year for a blood test and don't do any meds what so ever.I stopped all my bad habits and started taking the oils or resins from high grade marijuana that i had to ingest.Within six months my liver was normal again.It has to be ingested for it to work.Smoking isn't going to do it.Doctor don't want to hear about pain that the patients have to live with from the medications.AIDS and HIV patients have been using these marijuana resins for fiftenn years and some of tem are in better health now than they ever were because of this cannabis oil.Here is something so easy to use and make and it has no bad side affects,but yet you keep on looking for something that never cures anythink.I bet Timothy Ray Brown isn't looking for a cure that comes from dirt.Banned Ingredients that are still Legal in the US.Millions of people have read this and are starting to wonder if the FDA is such a good idea after all.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before adding your comment, please read TheBody.com's Comment Policy.) |